| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoimmune autonomic ganglionopathy: Ganglionic acetylcholine receptor autoantibodies
|
Urriola, Nicolás
|
|
|
21 |
2 |
p.
|
artikel
|
| 2 |
Could oxytocin reduce autoimmune disease in COVID-19?
|
Diep, Phuoc-Tan
|
|
|
21 |
2 |
p.
|
artikel
|
| 3 |
Course monitoring of membranous nephropathy: Both autoantibodies and podocytes require multidimensional attention
|
Liu, Wenbin
|
|
|
21 |
2 |
p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
21 |
2 |
p.
|
artikel
|
| 5 |
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis
|
Goswami, Rudra Prosad
|
|
|
21 |
2 |
p.
|
artikel
|
| 6 |
“Fibromyalgia syndrome” related to Essure devices
|
Dernoncourt, Amandine
|
|
|
21 |
2 |
p.
|
artikel
|
| 7 |
Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19”
|
Hočevar, Alojzija
|
|
|
21 |
2 |
p.
|
artikel
|
| 8 |
Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge
|
Merlonghi, Gioia
|
|
|
21 |
2 |
p.
|
artikel
|
| 9 |
Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review
|
Hysa, Elvis
|
|
|
21 |
2 |
p.
|
artikel
|
| 10 |
Leflunomide: A safe and effective alternative in systemic lupus erythematosus
|
Carrión-Barberà, I.
|
|
|
21 |
2 |
p.
|
artikel
|
| 11 |
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management
|
Zheng, Yan
|
|
|
21 |
2 |
p.
|
artikel
|
| 12 |
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis
|
Wang, Minhui
|
|
|
21 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving